Miscellaneous News - 2020-08-11 13:21:05
Brighton and Sussex Medical School (BSMS) is pleased to announce that it has received a £1 million donation from pharmaceutical company, Pfizer (UK).
Medical Science News - 2020-08-11 13:12:52
Functional genomics and proteomics have been quite successful in identifying functions of potential therapeutic targets such as encoded proteins.
Miscellaneous News - 2020-08-11 14:21:48
Health minister John Hutton today launched the national roll out of an online recruitment service for the NHS, which allows the public to search and apply for NHS jobs on one website.
Miscellaneous News - 2020-08-11 13:12:07
Three Limits of Human Performance debates will take place around the country as part of the etb's year-long Engineering in the Olympics campaign showcasing the sector's contribution to the Olympic experience.
Pharmaceutical News - 2020-08-11 13:11:56
Myriad Genetics, Inc. today released new data on MPC-4505, its Neurokinin-1 (NK1) receptor antagonist, a drug candidate for chemotherapy-induced nausea and vomiting (emesis). MPC-4505 is a potent, orally bioavailable, CNS-penetrating, highly selective NK1 antagonist.
Miscellaneous News - 2020-08-11 14:21:53
Members of Greater Glasgow NHS board will consider the financial crisis at today's meeting. The same meeting is expected to take a decision on closing the Queen Mother's Maternity Hospital – a proposal which has already caused uproar in the west of Scotland and beyond.
Women's Health News - 2020-08-11 13:21:30
Young women who took iron supplementation for 16 weeks significantly improved their attention, short-term and long-term memory, and their performance on cognitive tasks, even though many were not considered to be anemic when the study began, according to researchers at Pennsylvania State University.
Women's Health News - 2020-08-11 14:21:18
Ethylene glycol methyl ether a solvent for nitrocellulose, oils and resins, adhesives and for many different purposes may raise the risk of breast or ovarian cancer among women taking hormone treatments, say researchers at Duke University.